Japan Neuraminidase Inhibitors Market (2025-2031) | Share, Companies, Competitive Landscape, Growth, Industry, Outlook, Value, Size & Revenue, Segmentation, Forecast, Trends, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, 2021 & 2031F

3.3 Japan Neuraminidase Inhibitors Market - Industry Life Cycle

3.4 Japan Neuraminidase Inhibitors Market - Porter's Five Forces

3.5 Japan Neuraminidase Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Japan Neuraminidase Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Japan Neuraminidase Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Japan Neuraminidase Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 Japan Neuraminidase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of influenza in Japan

4.2.2 Rising awareness and education about the benefits of neuraminidase inhibitors

4.2.3 Government initiatives to promote vaccination and antiviral medication usage

4.3 Market Restraints

4.3.1 High cost associated with neuraminidase inhibitors

4.3.2 Competition from alternative treatments for influenza

4.3.3 Regulatory hurdles and approval process for new neuraminidase inhibitors

6.1 Japan Neuraminidase Inhibitors Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type A, 2021- 2031F

6.1.4 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Influenza Virus Type B, 2021- 2031F

6.1.5 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.2 Japan Neuraminidase Inhibitors Market, By Product

6.2.1 Overview and Analysis

6.2.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Zanamivir, 2021- 2031F

6.2.3 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Oseltamivir, 2021- 2031F

6.2.4 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Peramivir, 2021- 2031F

6.2.5 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Laninamivir, 2021- 2031F

6.2.6 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Other, 2021- 2031F

6.3 Japan Neuraminidase Inhibitors Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Inhalation, 2021- 2031F

6.3.4 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.5 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.4 Japan Neuraminidase Inhibitors Market, By End User

6.4.1 Overview and Analysis

6.4.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Others, 2021- 2031F

6.5 Japan Neuraminidase Inhibitors Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Japan Neuraminidase Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Japan Neuraminidase Inhibitors Market Export to Major Countries

7.2 Japan Neuraminidase Inhibitors Market Imports from Major Countries

8.1 Patient adherence rate to neuraminidase inhibitors treatment

8.2 Number of influenza cases reported annually in Japan

8.3 Rate of prescriptions for neuraminidase inhibitors compared to other antiviral medications

9.1 Japan Neuraminidase Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Japan Neuraminidase Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Japan Neuraminidase Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Japan Neuraminidase Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 Japan Neuraminidase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Japan Neuraminidase Inhibitors Market Revenue Share, By Companies, 2024

10.2 Japan Neuraminidase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters